The number of shares and votes in Vimian Group AB (publ) (“Vimian”) increased during June as a result of share subscriptions through the exercise of warrants as part of the warrant program adopted by Viman’s Annual General Meeting on 2 June 2023. In total, the number of shares has increased by 1,093,738 ordinary shares and the same number of votes.
Today, the last trading day of the month, there are a total of 530,356,375 shares in Vimian. 527,058,510 shares are ordinary shares with one vote per share. 938,605 shares are C shares, 1,485,532 shares are D shares, 291,237 shares are E1 2025 shares, 291,244 shares are E2 2025 shares, and 291,247 shares are E3 2025 shares, each with one-tenth of a vote per share. The total number of votes in Vimian is 527,388,296.5.
For further information, please contact:
Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
+46 73 626 88 86
About Vimian
Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches veterinary clinics and laboratories in over 80 markets, has 1,300 employees and annual revenues of approximately EUR 425 million. For more information, please visit: www.vimian.com.
This information is information that Vimian Group is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2026-06-30 17:30 CEST.
Attachments